Category: Latest News

The Multiple Sclerosis Associa …

In an effort to provide accura …

The Multiple Sclerosis Association of America advocates equally for all members of the MS community, and supports all peaceful efforts aimed at erasing the inequalities that exist between people of different races, religions, gender, and economic backgrounds, as well as those with disabilities. MSAA recognizes the inequities and overwhelming pain associated with discrimination and senseless acts of injustice.

Reviewed by MSAA Chief Medical …

Challenges presented by the CO …

On April 30, 2020, Banner Life Sciences LLC (Banner), a privately held specialty pharmaceutical company, announced the United States Food and Drug Administration (FDA) approval of Bafiertam™ (monomethyl fumarate) delayed-release oral capsules to treat relapsing forms of multiple sclerosis (MS). This approval includes the treatment of clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary-progressive MS (SPMS). Banner has not yet announced when the medication will be available to the MS community.

Reviewed by MSAA Chief Medical …

The “coronavirus disease 2019” (COVID-19) is a potentially serious respiratory disease that was first reported in December 2019 in China. As of early March 2020, the illness had made its way to almost 70 locations, including the United States, and has affected more than 90,000 individuals worldwide. Please be aware that these figures are expected to increase on a weekly or even a daily basis.

The Multiple Sclerosis Associa …

The Multiple Sclerosis Associa …